NRGN and injury: Unlike traditional biomarkers such as GFAP and NFL, which reflect glial and axonal injury, respectively, neurogranin highlights the synaptic dimension of brain trauma, which is highly relevant for cognitive outcomes and risk of later neurodegeneration.